Aptahem present preclinical progress of the company’s lead candidate Apta-1 at the world's largest conference for intensive care
Aptahem (publ) announced today that a presentation entitled "Apta-1, a novel RNA aptamer, improves outcome in an animal model of sepsis" will be held at the World Congress of Intensive Care in Melbourne, Australia, October 14-18, 2019. This conference is one of the most important in the field bringing together the world's leading clinicians and decision makers within intensive care.“This is the first time we are orally presenting the results of Apta-1 directly to clinicians working in the field of intensive care, which is an important milestone for our company”, says CSO Luiza Jedlina. “
Frankenthal/Worms, 7 October 2019 – Following the agreement on a change in the ownership structure of JM Holding GmbH and therefore also of RENOLIT SE and RKW SE, the restructuring process has now been completed. After the reorganisation of the ownership structure was contractually signed off in July, the redistribution between family owners came into effect on 1 October 2019.Upon completion of the reorganisation, the Fischer and Lang/Helms family members acquired all the shares in JM Holding GmbH and therefore also in RENOLIT SE, while the Müller and de Alvear family members received 100%
